Press What’s news at AbelsonTaylor Group
Select category
Agency 100 Studio Session: AbelsonTaylor | The future of generative AI in pharma marketing
AT’s VP – Director of Engagement Strategy Sharlene Jenner discusses some of the opportunities and challenges generative AI will bring in the future of pharma marketing. Through this podcast, Sharlene discusses how marketers must bring their teams together to maximize the new technology, while also trying to gain a better understanding of privacy laws, and intellectual property protection.
Read more at MM+M Online.
Media Contact:
Recent Posts
AbelsonTaylor Group Named PM360 Trailblazer Finalists in Nine Categories
AbelsonTaylor Group has been named a finalist in nine categories of the 2023 Trailblazer Awards. The finalists are: Professional Website/Online...
Read Press Read more AbelsonTaylor Group Named PM360 Trailblazer Finalists in Nine CategoriesSeres Therapeutics and Nestle Health Science Marketing Teams Named PM360 Trailblazer 2023 Finalist For Marketing Team of The Year
PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, has named Seres Therapeutics...
Read Press Read more Seres Therapeutics and Nestle Health Science Marketing Teams Named PM360 Trailblazer 2023 Finalist For Marketing Team of The YearThe AI Revolution Has Arrived: Shaping the Next Generation of Pharma Marketing
Sharlene Jenner – VP Director of Engagement Strategy is joined by five industry professionals to discuss the impact AI has...
In the News Read more The AI Revolution Has Arrived: Shaping the Next Generation of Pharma MarketingConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising
